The scientist’s investigation covers issues in Immunology, Immune system, Vaccination, Cancer and Antigen. His studies in Immunotherapy, T cell, CD8, Immunity and Epitope are all subfields of Immunology research. His Immune system research focuses on subjects like Proinflammatory cytokine, which are linked to Interleukin 5, Inflammasome and Innate immune system.
Sjoerd H. van der Burg has researched Vaccination in several fields, including Vulvar Diseases, Dendritic cell, Immunogenicity, Adjuvant and Nivolumab. Within one scientific family, Sjoerd H. van der Burg focuses on topics pertaining to Clinical trial under Cancer, and may sometimes address concerns connected to Alternative medicine. The various areas that Sjoerd H. van der Burg examines in his Antigen study include Efficacy, Oncolytic virus and Bioinformatics.
His main research concerns Immunology, Immune system, Immunotherapy, Cancer and Antigen. The study of Immunology is intertwined with the study of Cytotoxic T cell in a number of ways. His work carried out in the field of Cytotoxic T cell brings together such families of science as Epitope and Major histocompatibility complex.
His studies examine the connections between Immune system and genetics, as well as such issues in Cancer research, with regards to Antibody and Cancer cell. His research integrates issues of ELISPOT, Adoptive cell transfer, Immunogenicity and Peptide vaccine in his study of Immunotherapy. In his research on the topic of Cancer, Chemotherapy is strongly related with Oncology.
Sjoerd H. van der Burg mostly deals with Cancer research, Immune system, Immunotherapy, Cancer and Antigen. His Cancer research research is multidisciplinary, incorporating elements of Immune checkpoint, Cytotoxic T cell and Downregulation and upregulation. Immune system is the subject of his research, which falls under Immunology.
His Immunotherapy research integrates issues from Blockade, CD8, Pancreatic cancer and Adenocarcinoma. His biological study spans a wide range of topics, including Clinical efficacy and Immunosuppression. His studies in Antigen integrate themes in fields like Serology and Bioinformatics.
His primary areas of study are Immune system, Cancer research, T cell, Cytotoxic T cell and Cancer. His Immune system research includes elements of Myeloid and Vaccination. His work in Cancer research tackles topics such as Antigen which are related to areas like Cancer cell.
His T cell study combines topics in areas such as CD8 and Immunotherapy. In his research, Clinical trial is intimately related to Oncology, which falls under the overarching field of Cancer. His Cancer immunotherapy study is focused on Immunology in general.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik.
The New England Journal of Medicine (2009)
Comprehensive control of human papillomavirus infections and related diseases.
F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Cornelis J.M. Melief;Sjoerd H. van der Burg.
Nature Reviews Cancer (2008)
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
Sander Zwaveling;Sandra C. Ferreira Mota;Jan Nouta;Mark Johnson.
Journal of Immunology (2002)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4 + T cells in human melanoma
Carsten Linnemann;Marit M van Buuren;Laura Bies;Els M E Verdegaal.
Nature Medicine (2015)
Identification and manipulation of tumor associated macrophages in human cancers
Moniek Heusinkveld;Sjoerd H van der Burg.
Journal of Translational Medicine (2011)
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon;Liang Zheng;Katrin Meissl;Barbara Chaneton.
Vaccines for established cancer: overcoming the challenges posed by immune evasion.
Sjoerd H. van der Burg;Ramon Arens;Ferry Ossendorp;Thorbald van Hall.
Nature Reviews Cancer (2016)
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Marij J P Welters;Gemma G Kenter;Sytse J Piersma;Annelies P G Vloon.
Clinical Cancer Research (2008)
Therapeutic cancer vaccines
Cornelis J.M. Melief;Thorbald van Hall;Ramon Arens;Ferry Ossendorp.
Journal of Clinical Investigation (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: